Meet Dr. Kelly Olino
September 21, 2021Information
Dr. Olino is a surgical oncologist that specializes in the care of patients with advanced skin cancers and sarcomas and she discusses how she collaborates with other disciplines to provide patients with a cohesive experience.
ID6913
To CiteDCA Citation Guide
- 00:00Hi, my name is Kelly Olino.
- 00:03I'm a surgical oncologist,
- 00:04and at the Yale Cancer Center I treat
- 00:07patients with advanced skin cancers including
- 00:09Melanoma and Merkel cell carcinomas,
- 00:11and in addition to that I'm also an
- 00:14expert in the treatment of sarcoma.
- 00:16We're very fortunate that we really
- 00:18have a wonderful team approach from
- 00:21the minute patient picks up the phone,
- 00:23the person that they speak to on the
- 00:26other end really enables for us to have
- 00:29a seamless transition from their first.
- 00:31Appointment to the clinic visit.
- 00:34We have a multidisciplinary group of people
- 00:36and that includes surgeons like myself,
- 00:39plastic surgery,
- 00:40dermatology as well as medical
- 00:43oncology which really allows for
- 00:45both our skin cancer patients and
- 00:47our sarcoma patients to really have
- 00:50one stop access to all of their
- 00:52providers and for it to really be a
- 00:55very cohesive and seamless experience.
- 00:58Patients should always feel free
- 01:00to bring lists of questions.
- 01:02And concerns, because, again,
- 01:04there's so much information via
- 01:05in the Internet and social media.
- 01:07I'd much rather people come in with
- 01:10questions that they have and use me
- 01:12as almost their own personal medical
- 01:14encyclopedia and have every single
- 01:16one of those questions answered by the
- 01:18time that the clinic visit is over.
- 01:21And again to know that if they
- 01:23have additional questions,
- 01:24it's always OK to call again one
- 01:26of the main focus that we have,
- 01:29particularly with Melanoma,
- 01:30which was one of the early successes.
- 01:32In the treatment of immune therapy is
- 01:35to see how we can improve the platform,
- 01:38both in how we can minimize side
- 01:41effects while increasing the
- 01:42number of people who respond.
- 01:44For example,
- 01:45work that we've done and successfully
- 01:48taken from the laboratory now
- 01:50to the clinic has focused on
- 01:52a new target known as CD 40,
- 01:54and that actually led to us enabling
- 01:56to open a clinical trial which is
- 01:59now under active investigation,
- 02:01which really was the culmination.
- 02:03Of this seamless teamwork that
- 02:04I alluded to earlier,
- 02:06where patients have the benefit of us
- 02:08going from the bench to the bedside
- 02:10and then back to the bench to try
- 02:13and improve upon our treatments.